Tricaprilin In Age-Associated Memory Impairment

Completed · Phase 2 · Has a placebo group

Conditions studied: Age-Associated Memory Impairment

In brief

The purpose of this study is to determine whether tricaprilin, a compound that increases energy availability in the brain, improves memory in older adults with "normal" loss of memory abilities since early adult life.

Key facts

Study ID

NCT00355550

Run by

Cerecin

People needed

156

Starts

2006-07-01

Expected to finish

2007-06-01

Last updated by the study team

2020-09-18

Who can join

Age: 50 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Complaints that memory has declined since young adult life
• Scores on standardized tests that are at least one standard deviation below the mean score of young adults

You may not qualify if…

• Dementia, including Alzheimer's disease and Mild Cognitive Impairment (MCI)
• Drugs that impair cognition
• Psychiatric conditions that may impair cognition (e.g.,depression etc.)

Where it is running

• Meridien Research — Brooksville, Florida, United States
• University Clinical Research-DeLand — DeLand, Florida, United States
• Anchor Research Center — Naples, Florida, United States
• Renstar Medical Research — Ocala, Florida, United States
• University Clinical Research Center — Pembroke Pines, Florida, United States
• Meridien Research — St. Petersburg, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.